66
Participants
Start Date
February 28, 2014
Primary Completion Date
April 30, 2014
Study Completion Date
May 31, 2014
N6022
Intravenous solution of N6022 in normal saline administered by infusion pump over 1-8 minutes depending on the dose
Normal saline
Intravenous solution of 0.9% (weight/volume) NaCl administered by infusion pump over 1-8 minutes depending on dose of active drug used in same cohort
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Johns Hopkins Hospital, Baltimore
University of North Carolina, Chapel Hill
University of Alabama, Birmingham
Nationwide Children's Hospital, Columbus
Rainbow Babies and Children's Hospital - Case Medical Center, Cleveland
Cincinnati Children's Hospital, Cincinnati
University of Iowa Children's Hospital, Iowa City
University of Minnesota, Minneapolis
Northwestern University, Chicago
Washington University, St Louis
Children's Hospital Colorado, Aurora
National Jewish Health, Denver
Stanford University, Palo Alto
Providence Alaska Medical Center, Anchorage
Boston Children's Hospital, Boston
Lead Sponsor
Nivalis Therapeutics, Inc.
INDUSTRY